MYUNGMOON Pharm co.,Ltd (KRX:017180)
South Korea · Delayed Price · Currency is KRW 1,283.00
-37.00 (-2.80%)
Jun 10, 2026, 3:30 PM KST
MYUNGMOON Pharm co.,Ltd Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 3,025 | 1,895 | -3,035 | -4,525 | 7,868 | -6,865 |
Depreciation & Amortization | 3,939 | 3,962 | 4,066 | 4,168 | 4,238 | 4,203 |
Loss (Gain) From Sale of Assets | -25.85 | -22.85 | 512.21 | -25.61 | 14.03 | -895.37 |
Asset Writedown & Restructuring Costs | - | - | 854.35 | 736.22 | 4.2 | 448.76 |
Loss (Gain) From Sale of Investments | -35.64 | -30.27 | -63.24 | 36.24 | -95.02 | -498.6 |
Provision & Write-off of Bad Debts | -3,825 | -3,985 | -2,389 | -1,638 | 355.68 | -2,973 |
Other Operating Activities | 5,464 | 4,586 | 1,299 | 2,105 | -1,397 | 1,761 |
Change in Accounts Receivable | 246.75 | -792.98 | -2,181 | -2,232 | -2,294 | -527.37 |
Change in Inventory | -9,254 | -6,988 | -2,292 | -4,831 | -65.95 | 4,214 |
Change in Accounts Payable | -240.29 | -2,002 | 635.44 | 1,070 | 2,045 | -2,272 |
Change in Income Taxes | - | - | - | - | - | 39.78 |
Change in Other Net Operating Assets | -557.35 | 1,674 | 1,257 | -45.43 | -5,198 | 4,220 |
Operating Cash Flow | -1,263 | -1,704 | -1,338 | -5,181 | 5,475 | 855 |
Operating Cash Flow Growth | - | - | - | - | 540.33% | - |
Capital Expenditures | -5,386 | -6,758 | -771.52 | -2,983 | -1,731 | -374.71 |
Sale of Property, Plant & Equipment | 26.03 | 23.03 | 15.27 | 35.73 | 106.65 | 1,662 |
Sale (Purchase) of Intangibles | -4.7 | -73.1 | -631.48 | -7.62 | -153.68 | - |
Sale (Purchase) of Real Estate | - | - | - | - | 328.8 | 3,600 |
Investment in Securities | 66.57 | -171.36 | 1,509 | 4,305 | -2,540 | 4,240 |
Other Investing Activities | -100.01 | -260.81 | 20 | -23.67 | 85.25 | -0 |
Investing Cash Flow | -5,398 | -7,203 | 967.9 | 1,823 | -4,932 | 9,076 |
Short-Term Debt Issued | - | 3,404 | 39,350 | 33,837 | 21,422 | 8,490 |
Long-Term Debt Issued | - | 11,207 | 35,591 | 8,400 | 2,440 | 196.51 |
Total Debt Issued | 12,339 | 14,611 | 74,941 | 42,237 | 23,862 | 8,687 |
Short-Term Debt Repaid | - | -2,812 | -71,853 | -32,732 | -23,574 | -9,409 |
Long-Term Debt Repaid | - | -1,507 | -6,056 | -2,375 | -2,776 | -9,116 |
Total Debt Repaid | -4,368 | -4,319 | -77,910 | -35,108 | -26,350 | -18,525 |
Net Debt Issued (Repaid) | 7,971 | 10,292 | -2,969 | 7,130 | -2,488 | -9,839 |
Repurchase of Common Stock | - | - | -255.79 | -674.93 | - | - |
Dividends Paid | -23 | - | - | - | - | - |
Other Financing Activities | 31.12 | 30.62 | - | -0 | -15 | 2,158 |
Financing Cash Flow | 7,979 | 10,323 | -3,224 | 6,455 | -2,503 | -7,681 |
Foreign Exchange Rate Adjustments | 36.65 | 27.95 | 24.58 | 7.18 | 4.89 | 9.38 |
Miscellaneous Cash Flow Adjustments | -0 | - | 0 | - | -0 | 0 |
Net Cash Flow | 1,355 | 1,444 | -3,570 | 3,104 | -1,955 | 2,259 |
Free Cash Flow | -6,648 | -8,462 | -2,109 | -8,164 | 3,744 | 480.28 |
Free Cash Flow Growth | - | - | - | - | 679.57% | - |
Free Cash Flow Margin | -3.37% | -4.33% | -1.13% | -4.81% | 2.46% | 0.35% |
Free Cash Flow Per Share | -198.74 | -253.15 | -63.25 | -242.39 | 110.75 | 14.21 |
Cash Interest Paid | 5,116 | 5,110 | 5,725 | 5,133 | 3,590 | 3,027 |
Cash Income Tax Paid | 179.7 | 179.7 | -3.88 | 173.06 | -997.5 | 990.55 |
Levered Free Cash Flow | -9,407 | -11,754 | -3,728 | -6,513 | 322.87 | 9,476 |
Unlevered Free Cash Flow | -6,222 | -8,573 | -383.59 | -3,302 | 2,657 | 11,377 |
Change in Working Capital | -9,805 | -8,109 | -2,582 | -6,038 | -5,513 | 5,675 |